Advertisement

Topics

Sandoz International GmbH Company Profile

08:08 EST 24th November 2017 | BioPortfolio

Sandoz, a Novartis company, is a world leader in generic pharmaceuticals. The company develops, manufactures and markets these medicines as well as pharmaceutical and biotechnological active ingredients.In 2005, Sandoz acquired Hexal, one of Germany’s leading generics company, and Eon Labs, one of the fastest-growing generic pharmaceuticals companies in the US. These acquisitions significantly strengthen the Sandoz technology base, particularly in the application of “difficult-to-make” generics: transdermal patches, inhalation products, sustained-release implants and multi-particulate drug-delivery dosage forms. Also expanded are the traditionally strong capabilities in pharmaceuticals, biopharmaceuticals and anti-infectives.

Location

Industriestrasse 25
Holzkirchen
83607
Germany

Contact

Phone: 49 (0) 8024 476 0
Fax: 49 (0) 8024 476-2599
Email: info.sandoz@sandoz.com


News Articles [340 Associated News Articles listed on BioPortfolio]

Sandoz International GmbH Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 15062017] Prices from USD $350

Sandoz International GmbH Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Sandoz International GmbH Mergers Acquisitions MA, Partnerships Alliances and In...

Sandoz International GmbH Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 15102017] Prices from USD $350

Sandoz International GmbH Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Sandoz International GmbH Mergers Acquisitions MA, Partnerships Alliances and In...

Novartis International AG: Sandoz proposed biosimilar pegfilgrastim accepted by EMA for regulatory review

Novartis International AG / Sandoz proposed biosimilar pegfilgrastim accepted by EMA for regulatory review . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsibl...

Q&A: Sandoz’s Schofield discusses blueprint for AmLactin brand

Brant Schofield, VP and general manager of dermatology at Sandoz, shared with Drug Store News the blueprint for AmLactin’s growth under Sandoz. read more

Biosimilars Market is Expected to Grow at a CAGR of 26% from 2016 to 2023

Major key Players include Pfizer Inc,Teva Pharmaceuticals Industries Ltd,Sandoz International GmbH,Celltrion, Inc,Astra Zeneca,Amgen Inc.,F. Hoffmann-La Roche Ltd." PUNE, MAHARASHTRA, INDIA, July 7, 2...

Sandoz biosimilar Erelzi matches efficacy, safety profile of reference biologic in rheumatoid arthritis

Sandoz, a Novartis division and the global leader in biosimilars, announces results from the EQUIRA study. The phase III comparative safety and efficacy study shows that Sandoz biosimilar Erelzi

Sandoz reports clinical trial data on 2 biosimilars

Novartis unit Sandoz reported that its biosimilar version of adalimumab had safety and efficacy profiles similar to those of  -More- 

Novartis International AG: Sandoz expands partnership with World Child Cancer, to help children access treatment in four developing countries

Novartis International AG / Sandoz expands partnership with World Child Cancer, to help children access treatment in four developing countries . Processed and transmitted by Nasdaq Corporate Soluti...

PubMed Articles [702 Associated PubMed Articles listed on BioPortfolio]

The Supreme Court Ruling in Sandoz v Amgen: A Victory for Follow-on Biologics.

DIC in Decompensated Cirrhosis caused by Prothrombin Complex Concentrate and Recombinant Activated Factor VII: A Word of Caution.

We would like to respond to Scott et al. and the accompanying editorial.(1,2) Concentrated factor products like recombinant activated factor VII (NovoSeven(®) , Novo Nordisk Pharmaceuticals Inc.) an...

Evaluation of the anti-Acanthamoeba activity of two commercial eye drops commonly used to lower eye pressure.

Efficient treatments against Acanthamoeba Keratitis (AK), remains until the moment, as an issue to be solved due to the existence of a cyst stage which is highly resistant to most chemical and physica...

Torsional resistance of XP-endo Shaper at body temperature compared with several nickel-titanium rotary instruments.

To compare the torsional resistance of XP-endo Shaper (XPS; size 30, 0.01 taper, FKG Dentaire, La Chaux-de-Fonds, Switzerland) instruments at body temperature with TRUShape (TRS; size 30, 0.06 taper, ...

Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer.

The approval of injectable generic drugs does not require bioequivalence testing. However, although generic products contain the same level of the active compound, the levels and types of additives pr...

Clinical Trials [882 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.

This study will compare safety and efficacy of a generic rifaximin tablet to the reference listed drug in the treatment of travelers' diarrhea. Additionally both the generic and reference ...

To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fed Conditions

The purpose of this study is to Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fed Conditions.

To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cefzil 500 mg Cefprozil tablets under fasting conditions.

To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Dose Fasting Conditions.

The purpose of this study is to Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Dose Fasting Conditions.

Companies [1762 Associated Companies listed on BioPortfolio]

Sandoz GmbH

Nil

Lek Ljubljana Holding GmbH

Lek, a Sandoz company, is one of the pillars of leading world generics company Sandoz. It operates as a global development center for products and technologies, as a global manufacturing center for ac...

Sandoz Inc.

Sandoz, a Division of the Novartis group, is a global leader in the field of generic pharmaceuticals, offering a wide array of high-quality, affordable products that are no longer protected by patents...

Sandoz International GmbH

Sandoz, a Novartis company, is a world leader in generic pharmaceuticals. The company develops, manufactures and markets these medicines as well as pharmaceutical and biotechnological active ingredien...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

More Information about "Sandoz International GmbH" on BioPortfolio

We have published hundreds of Sandoz International GmbH news stories on BioPortfolio along with dozens of Sandoz International GmbH Clinical Trials and PubMed Articles about Sandoz International GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sandoz International GmbH Companies in our database. You can also find out about relevant Sandoz International GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record